Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases.
about
The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cellsMultigene families of immunoglobulin domain-containing innate immune receptors in zebrafish: deciphering the differencesTREM-1 as a potential therapeutic target in neonatal sepsis.Inactivation of DAP12 in PMN inhibits TREM1-mediated activation in rheumatoid arthritisTumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosisTLR-2/TLR-4 TREM-1 signaling pathway is dispensable in inflammatory myeloid cells during sterile kidney injury.Toll-like receptors, triggering receptor expressed on myeloid cells family members and receptor for advanced glycation end-products in allergic airway inflammationLipopolysaccharide induces TREM-1-dependent HIF-1α expression in human keratinocyte cell line.Levels of soluble TREM-1 in children with newly diagnosed type 1 diabetes and their siblings without type 1 diabetes: a Danish case-control study.Role of triggering receptor expressed on myeloid cells-1/3 in Klebsiella-derived pneumosepsis.Triggering receptor expressed on myeloid cells-1 (TREM-1) improves host defence in pneumococcal pneumonia.sTREM-1 in patients with chronic kidney disease on hemodialysis.Utility of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as biomarker to predict therapeutic response to methotrexate in rheumatoid arthritis.Serum sTREM-1 (soluble triggering receptor expressed on myeloid cells-1) associates negatively with embryo quality in infertility patients.Inhibition of innate co-receptor TREM-1 signaling reduces CD4(+) T cell activation and prolongs cardiac allograft survival.
P2860
Q27022093-6A79223C-4729-4954-A701-92537BB1A2AEQ33638985-7E08FC57-9E55-4ECC-A088-7A63F2D1FD06Q34042162-150B2C26-18F4-4F92-A213-FF9CFE6F72DFQ35038322-9D81DB20-991D-4EF0-8D84-662567A8204AQ36813491-885F6101-E413-450E-92A0-C57FD2ACA0CDQ36981043-9E923DAC-978A-4924-901A-F0C82D46903EQ37114498-FEFE798A-A6CA-4D1E-9B91-D1AC27D15730Q38734271-A29C7368-9668-4156-BAF3-2993894A1C06Q39174696-D08407CC-8C95-4E1F-88CF-068BBD30226AQ41346626-756AD542-5118-46B0-9336-05281E3E2E72Q43676807-80A17D8D-3E07-47BC-BEAB-FC73A390752FQ46363280-EDCCA424-CD9A-4BC5-9AEC-321FB7A0A91EQ47709408-0584164B-05FE-4269-9C48-5638BDA43265Q51369495-1ED060E0-8932-47EB-B788-2782E4AC6EE7Q54269836-C4C8AC8E-A270-4E1F-9328-8EF7BD6DDB45
P2860
Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Triggering receptor expressed ...... during inflammatory diseases.
@en
Triggering receptor expressed ...... during inflammatory diseases.
@nl
type
label
Triggering receptor expressed ...... during inflammatory diseases.
@en
Triggering receptor expressed ...... during inflammatory diseases.
@nl
prefLabel
Triggering receptor expressed ...... during inflammatory diseases.
@en
Triggering receptor expressed ...... during inflammatory diseases.
@nl
P2093
P2860
P356
P1433
P1476
Triggering receptor expressed ...... during inflammatory diseases.
@en
P2093
Frédéric Massin
Marc Derive
Sébastien Gibot
P2860
P304
P356
10.4161/SELF.1.3.12891
P577
2010-07-02T00:00:00Z